Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Epstein Barr Virus Quantitative PCR

Detects and measures the amount of Epstein Barr Virus (EBV) in your blood using a highly sensitive PCR test. Helps diagnose infections and monitor treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood (EDTA Vacutainer tube, 2ml), Serum, or Plasma.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Generally, no special preparation is required, but follow any specific instructions provided by your doctor or the laboratory.
Test priceKSh 12,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Epstein Barr Virus Quantitative PCR test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of infectious mononucleosis (fatigue, fever, sore throat, swollen lymph nodes)
  • ✓Monitoring EBV viral load in immunocompromised patients
  • ✓Diagnosis of EBV-related complications
  • ✓Patients with a history of EBV infection
  • ✓Pre-transplant evaluation
  • ✓Investigating unexplained lymphoproliferative disorders
02

In plain language

What this test helps you understand

This test helps detect and quantify the Epstein Barr Virus (EBV) in the blood. It is used to diagnose active EBV infections, monitor viral load in patients with known infections, and assess the risk of EBV-associated complications.
The Epstein Barr Virus (EBV) Quantitative PCR test is a diagnostic tool used to detect the presence and measure the quantity of EBV in the blood. This virus is known to cause infectious mononucleosis and is associated with several other diseases, including certain cancers. Understanding the level of EBV in the body can provide crucial insights into a person's health status and guide further medical decisions.

This test specifically measures the viral load of the Epstein Barr Virus in peripheral blood, serum, or plasma. It utilizes the Real-Time PCR method, which is highly sensitive and accurate, allowing for the early detection of the virus and monitoring of its activity in the body.

Taking the Epstein Barr Virus Quantitative PCR test offers numerous benefits, including early detection of EBV infections, monitoring the viral load in patients with known EBV infections, and assisting healthcare providers in making informed decisions regarding patient management and treatment plans.

Results from the test will indicate the viral load present in the sample. A higher viral load may suggest an active infection, while a lower or undetectable level may indicate a resolved or dormant infection. It is essential to discuss your results with a healthcare provider to understand their implications for your health.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Generally, no special preparation is required, but follow any specific instructions provided by your doctor or the laboratory.
SamplePeripheral blood (EDTA Vacutainer tube, 2ml), Serum, or Plasma.
MethodologyReal-Time PCR (Polymerase Chain Reaction).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects EBV DNA. It may not distinguish between active and latent infection in all cases. Results should be interpreted alongside clinical findings and other relevant tests. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

EBV is a common virus that most people are exposed to at some point in their lives. It is best known for causing infectious mononucleosis (mono) but can also be associated with other health issues.
Quantitative PCR (qPCR) is a sensitive method that not only detects the virus but also measures the amount (viral load) of EBV DNA present in the sample.
The results indicate the level of EBV DNA detected. A high viral load may suggest an active infection, while low or undetectable levels might indicate a resolved or dormant state. Your doctor will interpret these results in the context of your health.
Yes, a prescription from a doctor is typically required for this test, unless for specific reasons like surgery, pregnancy, or travel abroad. Please check with the laboratory.
The sample is usually collected via a blood draw using an EDTA tube. We offer sample collection at our branches or through a home collection service.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp